- Home
- YMAB vs CPS Comparison
YMAB vs CPS Comparison
Compare YMAB & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- CPS
- Stock Information
- Founded
- YMAB 2015
- CPS 1960
- Country
- YMAB United States
- CPS United States
- Employees
- YMAB N/A
- CPS N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- YMAB Health Care
- CPS Consumer Discretionary
- Exchange
- YMAB Nasdaq
- CPS Nasdaq
- Market Cap
- YMAB 218.4M
- CPS 208.1M
- IPO Year
- YMAB 2018
- CPS N/A
- Fundamental
- Price
- YMAB $3.89
- CPS $24.68
- Analyst Decision
- YMAB Buy
- CPS Hold
- Analyst Count
- YMAB 11
- CPS 1
- Target Price
- YMAB $18.73
- CPS $12.00
- AVG Volume (30 Days)
- YMAB 216.5K
- CPS 545.1K
- Earning Date
- YMAB 05-13-2025
- CPS 05-01-2025
- Dividend Yield
- YMAB N/A
- CPS N/A
- EPS Growth
- YMAB N/A
- CPS N/A
- EPS
- YMAB N/A
- CPS N/A
- Revenue
- YMAB $87,685,000.00
- CPS $2,721,537,000.00
- Revenue This Year
- YMAB N/A
- CPS $5.20
- Revenue Next Year
- YMAB $18.83
- CPS $6.33
- P/E Ratio
- YMAB N/A
- CPS N/A
- Revenue Growth
- YMAB 3.38
- CPS N/A
- 52 Week Low
- YMAB $3.84
- CPS $10.38
- 52 Week High
- YMAB $17.47
- CPS $26.42
- Technical
- Relative Strength Index (RSI)
- YMAB 40.44
- CPS 76.08
- Support Level
- YMAB $3.76
- CPS $14.02
- Resistance Level
- YMAB $4.60
- CPS $14.96
- Average True Range (ATR)
- YMAB 0.33
- CPS 1.54
- MACD
- YMAB -0.02
- CPS 1.32
- Stochastic Oscillator
- YMAB 15.12
- CPS 86.36
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.